Literature DB >> 6282652

Vascular smooth muscle in hypertension.

R J Winquist, R C Webb, D F Bohr.   

Abstract

The cause of the elevated arterial pressure in most forms of hypertension is an increase in total peripheral resistance. This brief review is directed toward an assessment of recent investigations contributing information about the factors responsible for this increased vascular resistance. Structural abnormalities in the vasculature that characterize the hypertensive process are 1) changes in the vascular media, 2) rarefication of the resistance vessels, and 3) lesions of the intimal vascular surface. These abnormalities are mainly the result of an adaptive process and are secondary to the increase in wall stress and/or to pathological damage to cellular components in the vessel wall. Functional alterations in the vascular smooth muscle are described as changes in agonist-smooth muscle interaction or plasma membrane permeability. These types of changes appear to play a primary, initiating role in the elevation of vascular resistance of hypertension. These alterations are not the result of an increase in wall stress and they often precede the development of high blood pressure. The functional changes are initiated by abnormal function of neurogenic, humoral, and/or myogenic changes that alter vascular smooth muscle activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282652

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  9 in total

1.  Effects of Bay K 8644 and nifedipine on femoral arteries of spontaneously hypertensive rats.

Authors:  K Aoki; M Asano
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

2.  Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension.

Authors:  T Pollare; H Lithell; I Selinus; C Berne
Journal:  Diabetologia       Date:  1988-07       Impact factor: 10.122

3.  Effect of exercise training on aortic collagen content in spontaneously hypertensive rats (SHR).

Authors:  M Higuchi; I Hashimoto; K Yamakawa
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1985

4.  Characterization of the rat basilar artery in vitro.

Authors:  R J Winquist; D F Bohr
Journal:  Experientia       Date:  1982-10-15

5.  Influence of neuronal uptake on the contribution of smooth muscle alpha 2-adrenoceptors to vasoconstrictor responses to noradrenaline in SHR and WKY isolated tail arteries.

Authors:  I C Medgett; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

6.  Effects of pheochromocytoma on cardiovascular alpha adrenergic receptor system.

Authors:  G Tsujimoto; K Hashimoto; B B Hoffman
Journal:  Heart Vessels       Date:  1985-08       Impact factor: 2.037

7.  Reactivity to bradykinin and potassium of the isolated duodenum from rats with genetic and renal hypertension.

Authors:  N Miasiro; T B Paiva; C C Pereira; S I Shimuta
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

8.  Differences in myocyte subpopulations from segments of the thoracic aorta and their modifications with age and hypertension in the rat.

Authors:  P Bodin; J C Stoclet; P Travo
Journal:  Cell Tissue Res       Date:  1987-01       Impact factor: 5.249

9.  Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.

Authors:  M Modan; H Halkin; S Almog; A Lusky; A Eshkol; M Shefi; A Shitrit; Z Fuchs
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.